Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 251

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 251
---
 as the grant date (as defined in ASC 718) had not been established.

Restricted Stock Units

Compensation cost for service-based RSUs is based on the grant date fair value of the award, which is the closing market price of the Company’s common stock on the grant date multiplied by the number of shares awarded.

The following table summarizes the Company’s RSU activity for the year ended December 31, 2024:

| Unvested balance, December 31, 2023 |     | Number 
 of     
 Units  
 -      |     |   | Weighted  
 Average   
 Grant     
 Date Fair 
 Value     
 -         |
|:------------------------------------|:----|:-------|:----|:--|:----------|
| Granted                             |     | -      |     |   | -         |
| Vested                              |     | -      |     |   | -         |
| Forfeited                           |     | -      |     |   | -         |
| Unvested balance, December 31, 2024 |     | -      |     | $ | -         |

The following table summarizes the Company’s RSU activity for the year ended December 31, 2023:

| Unvested balance, December 31, 2022 |     | Number of 
 Units     |      - |   |     | Weighted  
 Average   
 Grant     
 Date Fair 
 Value     |     - |
|:------------------------------------|:----|:----------|-------:|:--|:----|:----------|------:|
| Granted                             |     |           |  4,270 |   |     |           | 52.20 |
| Vested                              |     |           | (4,270 | ) |     |           | 52.20 |
| Forfeited                           |     |           |      - |   |     |           |     - |
| Unvested balance, December 31, 2023 |     |           |      - |   |     | $         |     - |

The Company recognized $0of compensation expense related to vested RSUs for the year ended December 31, 2024 ($ 222,480for the year ended December 31, 2023). During the year ended December 31, 2024, 0shares of common stock underlying RSUs vested ( 4,270during the year ended December 31, 2023). During the year ended December 31,